About: Recommandations CCAFU sur la prise en charge des cancers de l’appareil urogénital en période d’épidémie au Coronavirus COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recommandations CCAFU sur la prise en charge des cancers de l’appareil urogénital en période d’épidémie au Coronavirus COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Recommandations CCAFU sur la prise en charge des cancers de l’appareil urogénital en période d’épidémie au Coronavirus COVID-19
Source	Elsevier; Medline; PMC; WHO
abstract	Résumé Objectif La population française est confrontée à la pandémie de COVID-19 et le système de santé a été réorienté en urgence pour la prise en charge des patients atteints du coronavirus. La prise en charge des cancers de l’appareil urinaire et génital masculin doit être adaptée à ce contexte. Matériel et méthode Un avis d’experts documenté par une revue de la littérature a été formulé par le Comité de Cancérologie de l’Association Française d’Urologie (CCAFU). Résultats La prise en charge médicale et chirurgicale des patients atteints de cancers de l’appareil urinaire et génital masculin doit être adaptée en modifiant les modalités de consultation, en priorisant les interventions en fonction du pronostic intrinsèque des cancers en tenant compte des comorbidités du patient. La protection des urologues vis-à-vis du COVID-19 doit être prise en considération. Conclusion Le CCAFU émet un avis d’experts quant aux mesures à prendre pour adapter la prise en charge des cancers de l’appareil urinaire et génital masculin au contexte de pandémie par COVID-19. Summary Aim The French population is facing the COVID-19 pandemic and the health system have been reoriented in emergency for the care of patients with coronavirus. The management of cancers of the urinary and male genital tracts must be adapted to this context. Material and method An expert opinion documented by a literature review was formulated by the Cancerology Committee of the French Association of Urology (CCAFU). Results The medical and surgical management of patients with any cancers of the urinary and male genital tracts must be adapted by modifying the consultation methods, by prioritizing interventions according to the intrinsic prognosis of cancers, taking into account the patient's comorbidities. The protection of urologists from COVID-19 must be considered. Conclusion The CCAFU issues an expert opinion on the measure to be taken to adapt the management of cancers of the male urinary and genital tract to the context of pandemic by COVID-19.
has issue date	2020-03-30(xsd:dateTime)
bibo:doi	10.1016/j.purol.2020.03.009
bibo:pmid	32224294
has license	els-covid
sha1sum (hex)	60c98f70b0bad292b0157d0e3366762e93e3e16a
schema:url	https://doi.org/10.1016/j.purol.2020.03.009
resource representing a document's title	Recommandations CCAFU sur la prise en charge des cancers de l’appareil urogénital en période d’épidémie au Coronavirus COVID-19
has PubMed Central identifier	PMC7146722
has PubMed identifier	32224294
schema:publication	Prog Urol
resource representing a document's body	covid:60c98f70b0bad292b0157d0e3366762e93e3e16a#body_text
is schema:about of	named entity 'patients' named entity 'vis-à-vis' named entity 'Aim' named entity 'coronavirus' named entity 'context' named entity 'patient' named entity 'cancers' named entity 'les' named entity 'COVID-19 pandemic' named entity 'mois' named entity 'la balance' named entity 'IRM' named entity 'G-CSF' named entity 'COVID-19' named entity 'COVID-19' named entity 'La Société' named entity 'TVES' named entity '4 VIP' named entity 'CIS' named entity 'ifosfamide' named entity 'mois' named entity 'enzalutamide' named entity 'rapprocher' named entity 'SFRO' named entity 'IRM' named entity 'COVID-19' named entity '4 VIP' named entity 'G-CSF' named entity 'CIS' named entity 'étendue' named entity 'mois' named entity 'COVID-19' named entity 'G-CSF' named entity 'la stratégie' named entity 'mois' named entity 'd'Amico' named entity 'mois' named entity 'COVID-19' named entity 'COVID-19' named entity 'BCG' named entity 'thrombus' named entity 'COVID-19' named entity 'COVID-19' named entity 'G-CSF' named entity 'docetaxel' named entity 'TVES' named entity 'la rupture' named entity 'la 6' named entity 'sunitinib' named entity 'la stratégie' named entity 'GnRH' named entity 'G-CSF' named entity 'le port' named entity 'celle' named entity 'ifosfamide' named entity 'rapprocher' named entity 'nivolumab' named entity 'COVID-19' named entity 'enzalutamide' named entity 'apalutamide' named entity 'COVID-19' named entity 'mois' named entity 'COVID-19' named entity 'URS' named entity 'vitesse' named entity 'COVID-19' named entity 'COVID-19' named entity 'COVID-19' named entity 'Conclusion' named entity 'documented' named entity 'COVID-19' named entity 'PAND' named entity 'PAGES' named entity 'MASCULIN' named entity 'CONSULTATION' named entity 'PATIENTS' named entity 'PROTECTION' named entity 'CANCERS' named entity 'SUMMARY' named entity 'COVID-19' named entity 'endoscopes' named entity 'G-CSF'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software